Cardionovum

Be up
to date.

Latest press release

RESTORE® Drug-Coated Balloon receives first Chinese FDA medical device registration certificate for two indications

RESTORE®, CARDIONOVUM’s innovative paclitaxel-coated balloon for coronary applications has received market approval for China, making it the first drug-coated balloon (DCB) available in China to treat two indications: in-stent restenosis (ISR) and small vessel disease (SVD). The approval was given based on the impressive results from two solidly designed clinical studies in Chinese populations: RESTORE ISR CHINA and RESTORE SVD CHINA.

Learn more >>

J.C. van den Berg discusses results from the APERTO AVF study

Learn more >>

Koen Deloose discusses final results from the Reflow trial

Learn more >>

Matteo Tozzi discusses new data from the APERTO AVF study

Learn more >>

Dr. Bosier interview at LINC 2019

Learn more >>

CARDIONOVUM Press Release: RESTORE® Drug-Coated Balloon Matches Zotarolimus-Eluting Stent in Patients with Coronary Small Vessel Lesions

Learn more >>

Upcoming events

Currently there are no events.

Latest events

Cardionovum® at DGA Interventionskongress

Cardionovum® is pleased to invite you to visit us at booth #11

Location:

CONGRESSHALLE am Zoo Leipzig
Pfaffendorfer Straße 31
04105 Leipzig

Cardionovum® also invite you to attend the Live Case performed by Dr. Michael Lichtenberg on 23rd September from 12:30 to 13:00 in Weißer Saal (EG).

Date: Sep 21, 2023–Sep 24, 2023

Cardionovum® at CIRSE 2023

Cardionovum® is pleased to invite you to visit us at booth D10

Location:

Bella Center Copenhagen
Center Blvd. 5
2300, Copenhagen
Denmark

Date: Sep 09, 2023–Sep 13, 2023

Cardionovum® at LINC 2023

Cardionovum® is pleased to invite you to visit us at booth #19B

Location:

Leipziger Messe GmbH,
Hall 2, Messe-Allee 1,
04356, Leipzig,
Germany

Date: June 06, 2023–June 10, 2023

go top